These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 10599069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved labelling of no-carrier-added 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias.
    Samnick S, Bader JB, Müller M, Chapot C, Richter S, Schaefer A, Sax B, Kirsch CM.
    Nucl Med Commun; 1999 Jun; 20(6):537-45. PubMed ID: 10451866
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II).
    Prabhakar G, Mehra KS, Ramamoorthy N, Chattopadhyay S, Oommen R, Narasimhan S, Nair NA, Gunasekaran S.
    Appl Radiat Isot; 1999 Jun; 50(6):1011-4. PubMed ID: 10355103
    [Abstract] [Full Text] [Related]

  • 8. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I, Brandau W, Farmakis G, Samnick S.
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Establishment of a fast and high yield method for routine production of [(131) I]MIBG and investigation of its radiochemical stability for diagnosis and treatment uses.
    Davarpanah MR, Attar Nosrati S, Khoshhosn HA, Fazlali M, Kazemi Boudani M.
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):686-8. PubMed ID: 25196031
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An efficient batch preparation of high specific activity.
    Amartey JK, Al-Jammaz I, Lambrecht RM.
    Appl Radiat Isot; 2001 May; 54(5):711-4. PubMed ID: 11258518
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A kit method for the high level synthesis of [211At]MABG.
    Vaidyanathan G, Affleck DJ, Alston KL, Zhao XG, Hens M, Hunter DH, Babich J, Zalutsky MR.
    Bioorg Med Chem; 2007 May 15; 15(10):3430-6. PubMed ID: 17387017
    [Abstract] [Full Text] [Related]

  • 16. Effect of specific activity on cardiac uptake of iodine-123-MIBG.
    Farahati J, Bier D, Scheubeck M, Lassmann M, Schelper LF, Grelle I, Hanscheid H, Biko J, Graefe KH, Reiners C.
    J Nucl Med; 1997 Mar 15; 38(3):447-51. PubMed ID: 9074536
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of ESI-MS for semi-quantitative estimation of inactive precursor in no-carrier-added 131I- meta-Iodobenzylguanidine radiopharmaceutical preparation.
    Mathur A, Das S, Sakhare N, Sachdev SS.
    J Pharm Biomed Anal; 2019 Feb 20; 165():261-267. PubMed ID: 30562709
    [Abstract] [Full Text] [Related]

  • 20. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G, Zalutsky MR.
    Appl Radiat Isot; 1993 Mar 20; 44(3):621-8. PubMed ID: 8472027
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.